Author:
Richter Rudolf,Gupta Shipra,Forssmann Ulf
Reference61 articles.
1. Aubry, J. P., Power, C., Life, P., Schrader, M., & Bonnefoy, J. Y. (1995). Purification of human lung dendritic cells by three color flow cytometry. Advances in Experimental Medicine and Biology, 378, 89–91.
2. Barnes, P. J., Chung, K. F., & Page, C. P. (1998). Inflammatory mediators of asthma: An update. Pharmacological Reviews, 50, 515–596.
3. Berahovich, R. D., Miao, Z., Wang, Y., Premack, B., Howard, M. C., & Schall, T. J. (2005). Proteolytic activation of alternative CCR1 ligands in inflammation. Journal of Immunology, 174, 7341–7351.
4. Bodelon, C., Polley, M. Y., Kemp, T. J., Pesatori, A. C., McShane, L. M., Caporaso, N. E., et al. (2013). Circulating levels of immune and inflammatory markers and long versus short survival in early-stage lung cancer. Annals of Oncology, 24, 2073–2079.
5. Bosco, M. C., Puppo, M., Santangelo, C., Anfosso, L., Pfeffer, U., Fardin, P., et al. (2006). Hypoxia modifies the transcriptome of primary human monocytes: Modulation of novel immune-related genes and identification of CC-chemokine ligand 20 as a new hypoxia-inducible gene. Journal of Immunology, 177, 1941–1955.